Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy

HaEmek Medical Center, Israel80 enrolled

Overview

Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.

Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pregnancy

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * hypertension during pregnancy: Chronic or pregnancy induced Exclusion Criteria: * Inability to sign informed consent

Locations (1)

Ha'Emek Medical Center

Afula, Israel

Outcomes

Primary Outcomes

Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment

Time frame: 1 year

Secondary Outcomes

Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women

Time frame: 1 Year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.